Alight, Inc. / Delaware vs WEX
ALIT and WEX side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ALIT and WEX compare
WEX is the larger company, worth 18 times as much as Alight, Inc. / Delaware ($6.0B against $329M).
WEX grew revenue faster over the last twelve months (9.7% versus −3.5% for Alight, Inc. / Delaware).
WEX keeps more of each dollar of sales as profit, with a net margin of 14.0% compared with −90.9% at Alight, Inc. / Delaware.
Alight, Inc. / Delaware pays a dividend yielding 6.5%; WEX does not pay one.
WEX scores higher on the StockData Score (13 against 9 for Alight, Inc. / Delaware), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ALIT | WEX |
|---|---|---|
| Size and price | ||
| Market cap | $329M | $6.0B |
| Share price | $12.22 | $182.29 |
| Change, 1 year | −73.1% | 24.3% |
| Change, 5 years | −94.2% | 33.9% |
| Beta (5Y) | 1.31 | 1.03 |
| Employees | 9,500 | 6,600 |
| StockData Score | ||
| Total score | 9 | 13 (better) |
| Valuation score | 3 | 5 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 0 | 4 (better) |
| Health score | 2 (better) | 1 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | – | 15.7× |
| P/S | 0.1× (better) | 2.1× |
| P/B | 0.3× (better) | 5.2× |
| EV/EBITDA | – | 5.9× |
| P/FCF | 1.3× | – |
| PEG | – | 0.67 |
| FCF yield | 75.6% (better) | −5.2% |
| Fair value | $87.08 | $314.10 |
| Margin of safety | 86.0% (better) | 42.0% |
| Growth | ||
| Revenue growth (TTM) | −3.5% | 9.7% (better) |
| Revenue growth, 5Y average | −3.7% | 11.3% (better) |
| Net income growth (TTM) | – | 42.6% |
| EPS growth (TTM) | – | 51.3% |
| Profitability | ||
| Gross margin | 32.1% | 60.4% (better) |
| Operating margin | −95.7% | 26.6% (better) |
| Net margin | −90.9% | 14.0% (better) |
| FCF margin | 11.2% (better) | −10.8% |
| Return on equity | −97.9% | 35.6% (better) |
| Return on invested capital | −43.7% | 46.4% (better) |
| Financial health | ||
| Debt / equity | 1.95 (better) | 4.62 |
| Net debt / EBITDA | – | 0.05 |
| Interest coverage | −22.2× | – |
| Current ratio | 1.42 (better) | 1.03 |
| Altman Z-score | −2.23 | 0.83 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | 6.5% | – |
| Buyback yield | 7.6% (better) | 4.5% |
| Shareholder yield | 14.1% (better) | 4.5% |
| Ownership | ||
| Held by institutions | 67.3% | 121% |
| Held by insiders | – | 11.1% |
| Insider net buying, 12 months | −$98.3K (better) | −$53.6M |
| Short interest, % of float | – | 9.2% |
Go deeper
- ALIT stock overview
- ALIT income statement
- ALIT valuation and score
- WEX stock overview
- WEX income statement
- WEX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.